摘要
本文对小鼠继发性泡球蚴病用吡喹酮脂质体、吡喹酮、阿苯达唑、甲苯达唑、氟苯达唑进行化疗,对各组治疗期间的小鼠血清用间接血凝(IHA)、单克隆抗体(McAb)、斑点酶联免疫吸附试验(Dot-ELISA),分别检测循环抗体(CAb)和循环抗原(CAg)。结果表明,除阿苯达唑组小鼠血清抗体水平在治疗结束时下降明显,与对照组有显著差异外,其余各治疗组的抗体水平下降均不明显。各组治疗结束时,小鼠血清的CAg水平明显下降,与对照组有显著差异(P<0.01),表明检测循环抗原可作为疗效考核的指标之一。
In this paper,secondary cysts of Echinococcus multi-locularis in mice were treat-ed with praziquantel-liposome,praziquantel,albendazole,mebendazole and flubendazole.Duringthe treatment period,we continuously evaluated circulating antigen and antibody from mice seraof each treated group by means of IHA,McAb-Dot-ELISA.The results showed that there wereno significant difference in circulating antibody among the different treated groups except alben-dazole group which is significantiy different as compared with control group( P <0.05).The cir-culating antigen was greatly lower at the end of treatment in all treated groups as compared withcontrol group(P<0.01).It means that the circulating antigen can be considered as a indication oftherapeutic effect.
出处
《中国寄生虫病防治杂志》
CSCD
1994年第3期194-196,共3页
Chinese Journal of Parasitic Disease Control
关键词
循环抗原
循环抗体
泡球蚴病
疗效
Alveococcosis McAb circulating antigen circulating antibody.